Cerus Corporation (CERS) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $2.73 (+34.73%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 17, 2024 | Mathew Blackman | Stifel Nicolaus | $3.00 | +9.7% |
| May 3, 2024 | Brandon Folkes | Cantor Fitzgerald | $4.00 | +46.3% |
| Apr 12, 2024 | Bill Bonello | Craig-Hallum | $5.00 | +82.8% |
Top Analysts Covering CERS
CERS vs Sector & Market
| Metric | CERS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +46.3% | +1150.2% | +14.9% |
| P/E Ratio | -24.03 | 6.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $60M | $63M | $69M | 3 |
| 2026-09-30 | $61M | $64M | $70M | 1 |
| 2026-12-31 | $65M | $68M | $74M | 2 |
| 2027-03-31 | $58M | $62M | $67M | 1 |
| 2027-06-30 | $64M | $67M | $73M | 2 |
| 2027-09-30 | $66M | $69M | $76M | 2 |
| 2027-12-31 | $68M | $72M | $78M | 1 |
| 2028-12-31 | $299M | $312M | $326M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.04 | $-0.03 | $-0.02 | 2 |
| 2026-09-30 | $-0.01 | $-0.01 | $-0.01 | 1 |
| 2026-12-31 | $-0.00 | $-0.00 | $-0.00 | 1 |
| 2027-03-31 | $-0.06 | $-0.05 | $-0.05 | 1 |
| 2027-06-30 | $-0.04 | $-0.04 | $-0.04 | 1 |
| 2027-09-30 | $-0.01 | $-0.00 | $-0.00 | 1 |
| 2027-12-31 | $-0.03 | $-0.03 | $-0.03 | 1 |
| 2028-12-31 | $0.10 | $0.10 | $0.11 | 1 |
Frequently Asked Questions
What is the analyst consensus for CERS?
The consensus among 1 analysts covering Cerus Corporation (CERS) is Buy with an average price target of $4.00.
What is the highest price target for CERS?
The highest price target for CERS is $5.00, set by Bill Bonello at Craig-Hallum on 2024-04-12.
What is the lowest price target for CERS?
The lowest price target for CERS is $3.00, set by Mathew Blackman at Stifel Nicolaus on 2024-10-17.
How many analysts cover CERS?
1 analysts have issued ratings for Cerus Corporation in the past 12 months.
Is CERS a buy or sell right now?
Based on 1 analyst ratings, CERS has a consensus rating of Buy (2.00/5) with a +46.3% upside to the consensus target of $4.00.
What are the earnings estimates for CERS?
Analysts estimate CERS will report EPS of $-0.03 for the period ending 2026-06-30, with revenue estimated at $63M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.